The European Medicines Agency (EMA) today recommended adding a warning for two types of heart inflammation to Novavax’s COVID-19 vaccine, marketed under the brand names Nuvaxovid and Covovax, based on a small number of cases reported in those who received the vaccine. According to a statement, the EMA’s Pharmacovigilance Risk Assessment Committee — responsible for assessing and monitoring…

The U.S. Centers for Disease Control and Prevention (CDC) on Tuesday endorsed Novavax’s more conventional COVID-19 vaccine for use as a primary shot for eligible Americans aged 18 and older. The CDC’s independent advisory committee voted unanimously to recommend the vaccine for adults after reviewing safety and effectiveness data at a public meeting on Tuesday. Signing…

The U.S. Centers for Disease Control and Prevention (CDC) on Tuesday endorsed Novavax’s more conventional COVID-19 vaccine for use as a primary shot for eligible Americans aged 18 and older. The CDC’s independent advisory committee voted unanimously to recommend the vaccine for adults after reviewing safety and effectiveness data at a public meeting on Tuesday. Signing…

The U.S. Centers for Disease Control and Prevention (CDC) on Tuesday endorsed Novavax’s more conventional COVID-19 vaccine for use as a primary shot for eligible Americans aged 18 and older. The CDC’s independent advisory committee voted unanimously to recommend the vaccine for adults after reviewing safety and effectiveness data at a public meeting on Tuesday. Signing…

A top government regulator has said that Novavax’s spike protein-based COVID-19 vaccine listed severe allergies as a side effect, as the Food and Drug Administration (FDA) on Wednesday issued an emergency use authorization for the shot. The European Medicines Agency on Thursday said that (pdf) severe allergic reactions could be potential side effects of the…

The U.S. Food and Drug Administration (FDA) today granted Emergency Use Authorization (EUA) for the Novavax COVID-19 vaccine for adults 18 and over. The EUA is for the two-dose primary series targeting the original Wuhan SARS-CoV-2 virus — limiting the vaccine’s use, as about two-thirds of Americans already have completed a primary series of either the Pfizer, Moderna or Johnson…

The Food and Drug Administration’s (FDA) decision to authorize the Novavax COVID-19 vaccine for emergency use may be delayed due to the FDA reviewing changes to the company’s manufacturing process. Novavax told The Epoch Times that the company updated the FDA on changes to its manufacturing process on June 3, days before the advisory committee…

The Food and Drug Administration’s (FDA) decision to authorize the Novavax COVID-19 vaccine for emergency use may be delayed due to the FDA reviewing changes to the company’s manufacturing process. Novavax told The Epoch Times that the company updated the FDA on changes to its manufacturing process on June 3, days before the advisory committee…

A U.S. Food and Drug Administration (FDA) vaccine advisory panel voted on Tuesday to recommend the emergency use of Novavax’s COVID-19 vaccine. The advisory voted 21–0 with one abstention, after seven hours of discussion, agreeing that the benefits of a two-dose Novavax vaccine outweighed its risk for use in adults aged 18 and older. Dr….

A U.S. Food and Drug Administration (FDA) vaccine advisory panel voted on Tuesday to recommend the emergency use of Novavax’s COVID-19 vaccine. The advisory voted 21–0 with one abstention, after seven hours of discussion, agreeing that the benefits of a two-dose Novavax vaccine outweighed its risk for use in adults aged 18 and older. Dr….